BRPI0909030A2 - composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas. - Google Patents

composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas.

Info

Publication number: BRPI0909030A2
Authority: BR; Brazil
Prior art keywords: mycophenolate; pharmaceutical compositions; modified release; release pharmaceutical; processes therefor
Prior art date: 2008-03-05

Application number

BRPI0909030A

Other languages

English (en)

Inventor

Jain Rajesh

Singh Sukhjeet

Original Assignee

Panacea Biotec Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-05

Filing date

2009-03-04

Publication date

2018-03-13

2009-03-04 Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd

2018-03-13 Publication of BRPI0909030A2 publication Critical patent/BRPI0909030A2/pt

Links

HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 title 1
229940014456 mycophenolate Drugs 0.000 title 1
HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI0909030A 2008-03-05 2009-03-04 composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas. BRPI0909030A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN549DE2008		2008-03-05
PCT/IN2009/000148 WO2009110005A2 (en)	2008-03-05	2009-03-04	Modified release pharmaceutical compositions comprising mycophenolate and processes thereof

Publications (1)

Publication Number	Publication Date
BRPI0909030A2 true BRPI0909030A2 (pt)	2018-03-13

Family

ID=40863399

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0909030A BRPI0909030A2 (pt)	2008-03-05	2009-03-04	composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas.

Country Status (11)

Country	Link
US (1)	US20110008426A1 (pt)
EP (1)	EP2262483A2 (pt)
JP (1)	JP2011513391A (pt)
KR (1)	KR20100126465A (pt)
CN (1)	CN101969931A (pt)
AU (1)	AU2009220779A1 (pt)
BR (1)	BRPI0909030A2 (pt)
CA (1)	CA2717456A1 (pt)
EA (1)	EA201071035A1 (pt)
MX (1)	MX2010009704A (pt)
WO (1)	WO2009110005A2 (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7776314B2 (en)	2002-06-17	2010-08-17	Grunenthal Gmbh	Abuse-proofed dosage system
DE10361596A1 (de)	2003-12-24	2005-09-29	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070048228A1 (en)	2003-08-06	2007-03-01	Elisabeth Arkenau-Maric	Abuse-proofed dosage form
DE102005005446A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10336400A1 (de)	2003-08-06	2005-03-24	Grünenthal GmbH	Gegen Missbrauch gesicherte Darreichungsform
DE102004032049A1 (de)	2004-07-01	2006-01-19	Grünenthal GmbH	Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
SI2049123T1 (sl)	2006-08-03	2013-04-30	Horizon Pharma Ag	Zdravljenje revmatoznih bolezni z zadrĹľanim sproĹˇÄŤanjem glukokortikoida
DE102007011485A1 (de)	2007-03-07	2008-09-11	Grünenthal GmbH	Darreichungsform mit erschwertem Missbrauch
CA2713128C (en)	2008-01-25	2016-04-05	Gruenenthal Gmbh	Pharmaceutical dosage form
AU2009243681B2 (en)	2008-05-09	2013-12-19	Grunenthal Gmbh	Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
KR101738369B1 (ko)	2009-07-22	2017-05-22	그뤼넨탈 게엠베하	핫 멜트 압출된 제어 방출 투여형
CN102639118B (zh)	2009-07-22	2015-07-29	格吕伦塔尔有限公司	氧化稳定的抗干扰剂型
US20120141584A1 (en) *	2009-08-26	2012-06-07	Aptapharma, Inc.	Multilayer Minitablets
WO2011051967A2 (en) *	2009-10-23	2011-05-05	Alkem Laboratories Ltd	Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof
BR112013005194A2 (pt)	2010-09-02	2016-05-03	Gruenenthal Gmbh	forma de dosagem resistente à violação compreendendo sal inorgânico
TWI516286B (zh)	2010-09-02	2016-01-11	歌林達股份有限公司	含陰離子聚合物之抗破碎劑型
BR112014001091A2 (pt)	2011-07-29	2017-02-14	Gruenenthal Gmbh	comprimido resistente à adulteração que fornece liberação imediata do fármaco
EA201400172A1 (ru)	2011-07-29	2014-06-30	Грюненталь Гмбх	Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
MX356421B (es)	2012-02-28	2018-05-29	Gruenenthal Gmbh	Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
EP2838512B1 (en)	2012-04-18	2018-08-22	Grünenthal GmbH	Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en)	2012-05-11	2018-09-04	Gruenenthal Gmbh	Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
TW201503912A (zh) *	2013-03-19	2015-02-01	Novartis Ag	包含癌莫事（ｅｖｅｒｏｌｉｍｕｓ）之醫藥組合物
EP3003279A1 (en)	2013-05-29	2016-04-13	Grünenthal GmbH	Tamper-resistant dosage form containing one or more particles
US9737490B2 (en)	2013-05-29	2017-08-22	Grünenthal GmbH	Tamper resistant dosage form with bimodal release profile
BR112016000194A8 (pt)	2013-07-12	2019-12-31	Gruenenthal Gmbh	forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila
EP3073994A1 (en)	2013-11-26	2016-10-05	Grünenthal GmbH	Preparation of a powdery pharmaceutical composition by means of cryo-milling
WO2015173195A1 (en)	2014-05-12	2015-11-19	Grünenthal GmbH	Tamper resistant immediate release capsule formulation comprising tapentadol
EA201692388A1 (ru)	2014-05-26	2017-05-31	Грюненталь Гмбх	Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
WO2016170097A1 (en)	2015-04-24	2016-10-27	Grünenthal GmbH	Tamper-resistant dosage form with immediate release and resistance against solvent extraction
CA2986359A1 (en)	2015-05-20	2016-11-24	Novartis Ag	Pharmaceutical combination of everolimus with dactolisib
TWI722988B (zh) *	2015-06-05	2021-04-01	瑩碩生技醫藥股份有限公司	緩釋性醫藥組合物及其製備方法
JP2018526414A (ja)	2015-09-10	2018-09-13	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
US12059502B2 (en) *	2016-04-21	2024-08-13	Valcuria Ab	Composition and method for pretreating cancer
CN110114070A (zh)	2016-11-23	2019-08-09	诺华公司	使用依维莫司(everolimus)、达托里昔布(dactolisib)或二者增强免疫反应的方法
US11633378B2 (en) *	2017-03-13	2023-04-25	Okava Pharmaceuticals, Inc.	Methods and compositions for delivering mycophenolic acid active agents to non-human mammals
CN108066322A (zh) *	2018-02-01	2018-05-25	宁波蒙曼生物科技有限公司	一种吗替麦考酚酯缓释胶囊及其制备方法
US10596165B2 (en)	2018-02-12	2020-03-24	resTORbio, Inc.	Combination therapies
US10835489B2 (en)	2018-03-09	2020-11-17	University Of Saskatchewan	Modified release formulations of mycophenolate mofetil
JP2022506007A (ja) *	2018-09-07	2022-01-17	オカヴァファーマシューティカルズ，インコーポレイテッド	ミコフェノール酸活性剤を非ヒト哺乳動物に送達するための方法および組成物
JP6795238B1 (ja) *	2020-06-12	2020-12-02	竹本油脂株式会社	合成繊維用処理剤の製造方法、合成繊維用処理剤、合成繊維、及び合成繊維の製造方法
WO2023076568A1 (en) *	2021-10-29	2023-05-04	Neurocrine Biosciences, Inc.	Valbenazine compositions
CN114569570B (zh) *	2022-03-15	2023-03-24	浙江长典药物技术开发有限公司	一种吗替麦考酚酯及制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1258143B (it) *	1992-09-11	1996-02-20	Alfa Wassermann Spa	Compresse a cessione programmata contenenti naproxen
GB0124953D0 (en) *	2001-10-17	2001-12-05	Novartis Ag	Organic Compounds
US6913768B2 (en) *	2002-09-24	2005-07-05	Shire Laboratories, Inc.	Sustained release delivery of amphetamine salts
HRP20030324A2 (en) *	2003-04-24	2005-02-28	Pliva-Istra�iva�ki institut d.o.o.	Compounds of antiinflammatory effect
AR045957A1 (es) *	2003-10-03	2005-11-16	Novartis Ag	Composicion farmaceutica y combinacion
GB0419355D0 (en) *	2004-08-31	2004-09-29	Novartis Ag	Organic compounds
EP1802287A2 (en) *	2004-09-27	2007-07-04	Sigmoid Biotechnologies Limited	Minicapsule formulations
US20090023805A1 (en) *	2006-02-13	2009-01-22	Anne Claire Marrast	Method of administration

2009
- 2009-03-04 JP JP2010549258A patent/JP2011513391A/ja not_active Withdrawn
- 2009-03-04 CN CN2009801078161A patent/CN101969931A/zh active Pending
- 2009-03-04 US US12/920,512 patent/US20110008426A1/en not_active Abandoned
- 2009-03-04 EP EP09717394A patent/EP2262483A2/en not_active Withdrawn
- 2009-03-04 AU AU2009220779A patent/AU2009220779A1/en not_active Abandoned
- 2009-03-04 MX MX2010009704A patent/MX2010009704A/es not_active Application Discontinuation
- 2009-03-04 EA EA201071035A patent/EA201071035A1/ru unknown
- 2009-03-04 CA CA2717456A patent/CA2717456A1/en not_active Abandoned
- 2009-03-04 WO PCT/IN2009/000148 patent/WO2009110005A2/en not_active Ceased
- 2009-03-04 KR KR1020107022011A patent/KR20100126465A/ko not_active Withdrawn
- 2009-03-04 BR BRPI0909030A patent/BRPI0909030A2/pt not_active IP Right Cessation

Also Published As

Publication number	Publication date
MX2010009704A (es)	2010-12-20
CN101969931A (zh)	2011-02-09
US20110008426A1 (en)	2011-01-13
WO2009110005A3 (en)	2010-10-14
KR20100126465A (ko)	2010-12-01
AU2009220779A1 (en)	2009-09-11
JP2011513391A (ja)	2011-04-28
WO2009110005A2 (en)	2009-09-11
CA2717456A1 (en)	2009-09-11
EP2262483A2 (en)	2010-12-22
EA201071035A1 (ru)	2011-04-29

Legal Events

Date	Code	Title	Description
2018-03-20	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 5A, 6A, 7A, 8A E 9A ANUIDADES.
2018-07-10	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Publication	Publication Date	Title
BRPI0909030A2 (pt)	2018-03-13	composições farmacêuticas de liberação modificada compreendendo micofenolato e processos para as mesmas.
BRPI0918652A2 (pt)	2015-08-25	Composições farmacêuticas e métodos de libração relacionadas.
BRPI0919466A2 (pt)	2015-12-01	composição farmacêutica para liberação modificada
BRPI0910503A2 (pt)	2015-09-29	compostos, composições farmacêuticas e respectivos usos.
BRPI1010772A2 (pt)	2016-11-01	composto,e, composição farmacêutica.
BRPI0909780A2 (pt)	2015-08-11	Composições e métodos para liberação de fármaco
BRPI0906962A2 (pt)	2015-07-14	Composto, e, composição farmacêutica
BRPI0906556A2 (pt)	2015-07-07	Composto, e, composição farmacêutica
BR112012012108A2 (pt)	2016-04-05	composição farmacêutica compreendendo propofol
BRPI0718688A2 (pt)	2013-12-24	Composições de baixa irritação e métodos para preparar as mesmas.
BRPI0913447A2 (pt)	2015-12-01	composição de éster, e, composição para cuidado pessoal.
BRPI0818732A2 (pt)	2014-10-07	Composições de análogo de prostaglandina e métodos para tratar condições relacionadas epiteliais.
BRPI0917358A2 (pt)	2015-11-17	formulação farmacêutica de liberação controlada e método.
BRPI0815841A2 (pt)	2015-09-01	Métodos e composições para melhoramento de traços preferidos.
BRPI1010301A2 (pt)	2016-03-15	composição.
BRPI1009372A2 (pt)	2016-05-31	compostos, composição farmacêutica e respectivos usos
DK2285357T3 (da)	2014-06-02	Farmaceutisk sammensætning omfattende brivaracetam
BRPI0814745A2 (pt)	2014-10-07	Composição de produto.
NL2000690A1 (nl)	2007-12-11	Gestabiliseerde farmaceutische samenstellingen omvattende fesoterodine.
BRPI0917681A2 (pt)	2015-08-04	Composto, e, composição farmacêutica
BRPI0808032A2 (pt)	2014-06-17	Processos para preparar hidroxipivalinaldeído e para preparar neopentil glicol.
BRPI0813922A2 (pt)	2017-05-09	composições de inibição de influenza e métodos.
DK2285413T3 (da)	2012-08-27	Farmaceutisk sammensætning
BR112012003800A2 (pt)	2016-11-22	composição, peptídeo, e formulação farmacêutica.
BR112012000831A2 (pt)	2019-09-24	compostos, composições farmacêuticas e métodos relacionados